Skip to main content
Prime Securities Ltd. logo

Prime Securities Ltd. — Investor Relations & Filings

Ticker · PRIMESECU ISIN · INE032B01021 LEI · 335800M8UW96ZOVMGJ80 BSE.NS Financial and insurance activities
Open in API
Filings indexed 1,151 across all filing types
Latest filing 2023-01-31 Regulatory Filings
Country IN India
Listing BSE.NS PRIMESECU

About Prime Securities Ltd.

https://primesec.com/

Prime Securities Ltd. provides a range of corporate advisory and investment banking services. The firm specializes in mergers and acquisitions, private equity syndication, and capital restructuring for a diverse client base. Its service portfolio includes equity capital market transactions, debt syndication, and structured finance solutions. Prime Securities Ltd. focuses on delivering strategic financial guidance and customized engineering to facilitate growth and optimize capital structures. The company supports clients through complex financial transitions, offering expertise in institutional brokerage and wealth management. By leveraging deep market insights and an advisory-led approach, the firm aims to enhance shareholder value and provide comprehensive support for corporate growth initiatives and strategic decision-making.

Recent filings

Filing Released Lang Actions
Disclosure In Terms Of Regulation 32(1) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Statement Of Nil Deviation Or Variation
Regulatory Filings
2023-01-31 English
Unaudited (Consolidated and Standalone) Financial Results for the Third Quarter and Nine Months ended December 31, 2022
Regulatory Filings
2023-01-31 English
Financial Result Updates
Regulatory Filings
2023-01-31 English
PRIME SECURITIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2023 ,inter alia, to consider and approve Unaudited Financial Results ....
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges informing them about a scheduled Board of Directors meeting to consider and approve the unaudited financial results for the third quarter and nine months ended December 31, 2022. It references Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of events or information by listed entities. The document does not contain the financial results themselves, only a notice of the upcoming board meeting where these results will be approved. The document length is short (1562 characters) and it serves as an announcement rather than a report. Therefore, it is not an Interim/Quarterly Report (IR) but rather a Regulatory Filing (RNS) as a general regulatory announcement about an upcoming event related to financial results.
2023-01-23 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges informing them about a scheduled Board of Directors meeting to consider and approve the unaudited financial results for the third quarter and nine months ended December 31, 2022. It references Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of events or information by listed entities. The document does not contain the financial results themselves but is a notification about the upcoming approval of such results. The document length is short (1562 characters) and serves as an announcement rather than the actual financial report. Therefore, it is best classified as a Regulatory Filing (RNS) since it is a general regulatory announcement and does not contain substantive financial data or the report itself.
2023-01-23 English
Updates
Regulatory Filings
2023-01-18 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.